▲ Peaking
Health
New weight loss pill that’s beating oral Ozempic
A new oral GLP-1 receptor agonist is demonstrating clinical performance in weight loss and glucose management, outperforming rival treatments.
Glp-1
21 trends tracked about this subject — the full history, oldest to newest below.
↓ Cooling
Business
🔮 fades
A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss
Novo Nordisk has entered into a partnership with Vivani to develop a long-acting semaglutide implant designed for weight management.
◼ Archived
Health
🔮 fades ✓
Ozempic Face, Blindness Claims, And Billions In Potential Damages: The GLP-1 Reckoning
Public scrutiny regarding the mental, physical, and legal implications of GLP-1 receptor agonists intensifies amid reports of potential litigation.
◼ Archived
Health
🔮 fades ✓
Something Strange Is Happening to Athletes Who Take GLP-1s. Experts Are Racing to Find Out Why.
4 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Health
🔮 fades ✗
Healthy Returns: Employers aren't expanding coverage of GLP-1 obesity drugs
Employers and public health programs are limiting access to GLP-1 obesity drugs due to rising costs and budget constraints.
◼ Archived
Business
🔮 fades ✓
Nestlé to Tweak Some Food Recipes to Appeal to Duller GLP-1 Palates
Nestlé is adjusting food recipes as the rise of GLP-1 weight-loss drugs alters consumer taste preferences and shopping habits.
◼ Archived
Business
🔮 fades ✗
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
GLP-1 weight loss drugs are being used by a record number of Americans.
◼ Archived
Health
🔮 fades ✓
Wegovy weight loss pill now available in UK
Wegovy has launched a daily oral pill for weight management in the UK, marking a shift from injectable treatments to pharmacy-available medication.
◼ Archived
Business
🔮 fades ✗
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Eli Lilly's market value surges as Kailera's weight-loss pill faces market setbacks despite successful clinical efficacy in China.
◼ Archived
Health
🔮 fades ✗
Ozempic skin side effects are more common than you think
The rise of GLP-1 medications like Ozempic is creating a new surge in demand for plastic surgery and aesthetic medicine to treat skin side effects.
◼ Archived
Health
🔮 fades ✓
How easy is it to get weight-loss drugs online? Secret shoppers from Yale found out.
A Yale secret shopper study reveals significant gaps in the online prescribing process for GLP-1 obesity medications.
◼ Archived
Health
🔮 fades ✓
People Are Sharing The Things They Think Will Be “Inevitable Outcomes” Of GLP-1s Over The Next 20 Years
Public discourse and clinical research are shifting toward the long-term psychological and addictive-behavior impacts of GLP-1 medications.
◼ Archived
Health
🔮 fades ✓
Peptide hype is at an all-time high
Peptides have emerged as a dominant wellness trend, sparking a commercial gold rush alongside growing warnings about unregulated black-market usage.
◼ Archived
Business
🔮 fades ✓
Seniors in Medicare are about to get landmark obesity drug coverage
Starting July 1, 2026, Medicare will cover GLP-1 weight-loss drugs for seniors, marking a significant expansion in obesity treatment access.
◼ Archived
Business
🔮 fades ✓
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
Eli Lilly shares have hit a new all-time high following European regulatory progress and expanded access to GLP-1 treatments.
◼ Archived
Business
🔮 fades ✓
Why breakthrough GLP-1 weight loss pills may be a bad thing for employer insurance coverage
Employers are reconsidering coverage for popular GLP-1 weight loss drugs, leaving patients and insurers in limbo.
◼ Archived
Health
🔮 holds ✗
GLP-1 weight loss drugs may be misused by patients with eating disorders: Study
New research indicates that GLP-1 receptor agonists, including Ozempic, are being misused by individuals with eating disorders.
◼ Archived
Health
🔮 fades ✓
Medicare launches pilot program expanding access to GLP-1 drugs
Medicare's new pilot program expands access to GLP-1 drugs, sparking coverage on eligibility and potential impacts.
◼ Archived
Health
🔮 fades ✓
Popular weight-loss drugs linked to unexpected male fertility benefit
Recent data suggests GLP-1 weight-loss medications may provide unexpected fertility benefits for men.
◼ Archived
Health
🔮 fades ✓
Research shows weight-loss drugs may also reduce cancer risk
New research indicates GLP-1 receptor agonists used for weight loss may be linked to a reduced risk of certain cancers, specifically breast cancer.
◼ Archived
Health
🔮 fades ✓
Ozempic users may be making a major weight-loss mistake, new study suggests
New research indicates a trend of decreased physical activity among individuals using GLP-1 weight loss medications like Ozempic and Wegovy.